Sanofi Consumer Healthcare India Limited has informed the Exchange regarding Notice of Postal Ballot
SANOFICONR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sanofi Consumer Healthcare India has dispatched a Postal Ballot Notice seeking shareholder approval for two material related party transactions with group entities. The first is an additional Rs. 165 Million limit with Opella Healthcare India Private Limited (OHIPL), taking the total approved limit with OHIPL to Rs. 950 Million for FY ending 31 December 2025. The second is an additional Rs. 900 Million limit with Opella Healthcare International SAS (France), taking the total approved limit with Opella SAS to Rs. 2,000 Million for FY ending 31 December 2025. Both transactions cover services and sale/purchase of goods at arm's length in the ordinary course of business. Remote e-voting runs from 30 September 2025 to 29 October 2025, with results announced on or before 31 October 2025. Promoters, being related parties, will abstain from voting on these resolutions.
This is a procedural step required by SEBI Listing Regulations to continue and expand intra-group transactions. Approval is necessary for the company to carry out its planned business with Opella group entities, and is unlikely to materially affect the stock price barring any shareholder dissent.